CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II

被引:149
作者
Pietra, BA
Wiseman, A
Bolwerk, A
Rizeq, M
Gill, RG
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Med, Denver, CO 80262 USA
[2] Childrens Hosp, Div Cardiol, Denver, CO 80218 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Nephrol, Denver, CO 80262 USA
[4] Univ Colorado, Hlth Sci Ctr, Vet Affairs Med Ctr, Dept Pathol, Denver, CO 80262 USA
关键词
D O I
10.1172/JCI10467
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Numerous studies indicate that CD4 T cells are required for acute cardiac allograft rejection. However, the precise role for CD4 T cells in this response has remained ambiguous owing to the multipotential properties of this T-cell subpopulation. In the current study, we demonstrate the capacity of CD4 T cells to serve as direct effector cells of cardiac allograft rejection. We show that CD4 T cells are both necessary and sufficient for acute graft rejection, as indicated by adoptive transfer experiments in immune-deficient SCID and rag1(-/-) recipients. We have analyzed the contribution of direct (donor MHC class II restricted) and indirect (host MHC class II restricted) antigen recognition in CD4-mediated rejection. Acute CD4 T cell-mediated rejection required MHC class II expression by the allograft, indicating the importance of direct graft recognition. In contrast, reciprocal experiments indicate that CD4 T cells can acutely reject allogeneic cardiac allografts established in rag1(-/-) hosts that were also MHC class II deficient. This latter result indicates that indirect presentation of donor antigens by host MHC class II is not required for acute CD4-mediated rejection. Taken together, these results indicate that CD4 T cells can serve as effector cells for primary acute cardiac allograft rejection, predominantly via direct donor antigen recognition and independent of indirect reactivity.
引用
收藏
页码:1003 / 1010
页数:8
相关论文
共 42 条
  • [21] HAO L, 1987, J IMMUNOL, V139, P4022
  • [22] HERBERT J, 1988, TRANSPLANTATION, V46, pS128
  • [23] Cytotoxic pathways in the skin allograft rejection by CD4+ T cells
    Ito, A
    Minagawa, M
    Tomiyama, K
    Ito, M
    Kawai, K
    [J]. TRANSPLANTATION, 1999, 68 (01) : 97 - 100
  • [24] CD4(+) but not CD8(+) cells are essential for allorejection
    Krieger, NR
    Yin, DP
    Fathman, CG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) : 2013 - 2018
  • [25] CONTRIBUTION OF DIRECT AND INDIRECT RECOGNITION PATHWAYS TO T-CELL ALLOREACTIVITY
    LIU, Z
    SUN, YK
    XI, YP
    MAFFEI, A
    REED, E
    HARRIS, P
    SUCIUFOCA, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) : 1643 - 1650
  • [26] Indirect recognition of donor HLA-DR peptides in organ allograft rejection
    Liu, ZR
    Colovai, AI
    Tugulea, S
    Reed, EF
    Fisher, PE
    Mancini, D
    Rose, EA
    Cortesini, R
    Michler, RE
    SuciuFoca, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) : 1150 - 1157
  • [27] Mandelbrott DA, 1999, J IMMUNOL, V163, P3753
  • [28] INDEFINITE SURVIVAL OF MHC CLASS I-DEFICIENT MURINE PANCREATIC-ISLET ALLOGRAFTS
    MARKMANN, JF
    BASSIRI, H
    DESAI, NM
    ODORICO, JS
    KIM, JI
    KOLLER, BH
    SMITHIES, O
    BARKER, CF
    [J]. TRANSPLANTATION, 1992, 54 (06) : 1085 - 1089
  • [29] Onodera K, 1996, J IMMUNOL, V157, P1944
  • [30] Prevention of murine cardiac allograft rejection with gallium nitrate - Comparison with anti-CD4 monoclonal antibody
    Orosz, CG
    Wakely, E
    Bergese, SD
    VanBuskirk, AM
    Ferguson, RM
    Mullet, D
    Apseloff, G
    Gerber, N
    [J]. TRANSPLANTATION, 1996, 61 (05) : 783 - 791